Iron-ovotransferrin preparation does not interfere with ciprofloxacin absorption

Clinical Pharmacology and Therapeutics

Volumn 59, Issue 4, 1996, Pages 418-422

  Pazzucconi, Franco ^b   Barbi, Silvia ^b   Baldassarre, Damiano ^b   Colombo, Nicola ^b   Dorigotti, Fabio ^b   Sirtori, Cesare R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; FERROUS GLUCONATE; OVOTRANSFERRIN; PLACEBO; SIDEROGLOBIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CONALBUMIN; DRUG COMBINATIONS; HUMANS; INTESTINAL ABSORPTION; IRON COMPOUNDS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0029923883     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90110-1     Document Type: Article

References (23)

1. La Piana Simonsen L. Top 200 drugs of 1989. Pharm Times 1990;56:56-64.
2. Campbell NCR, Hasinoff BB, Stalts H, Rao B, Wong NCW. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992; 117:1010-3.
3. Neuvonen PJ, Gothoni G, Hackman K, Bjorksten K. Interferences of iron with the absorption of tetracyclines in man. Br Med J 1970;4:532-4.
4. Osman MA, Patel RB, Shuna A, Sundstrom WR, Welling PG. Reduction in oral penicillamine absorption by food, antacid and ferrous sulfate. CLIN PHARMACOL THER 1983;33:465-70.
5. Campbell NR, Campbell RR, Hasinoff B. Ferrous sulfate reduces methyldopa absorption: iron complex formation as a likely mechanism. Clin Invest Med 1990;13:329-32.
6. Campbell RR, Hasinoff B, Chernenko G, Barrowman J, Campbell NR. The effect of ferrous sulfate and pH on L-dopa absorption. Can J Physiol Pharmacol 1990;68: 603-7.
7. Campbell NR, Rankine D, Goodridge AE, Hasinoff BB, Kara M. Sinemet-ferrous sulfate interaction in patients with Parkinson's disease. Br J Clin Pharmacol 1990;30:599-605.
8. Polk RE, Healy DP, Sahai J, Drwal L, Racht E. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother 1989;33:1841-4.
9. Campbell NCR, Hasinoff BB. Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol 1991;31:251-5.
10. Kara M, Hasinoff BB, McKay DW, Campbell NCR. Clinical and chemical interactions between iron preparations and ciprofloxacin. Br J Clin Pharmacol 1991; 31:257-60.
11. Sahai J, Gallicano K, Oliveras L, Khaliq S, Hawley-Foss N, Garber G. Cations in the didanosine tablet reduce ciprofloxacin bioavailability. CLIN PHARMACOL THER 1993;53:292-7.
12. Lehto P, Kivistö KT, Neuvonen PJ. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin. Br J Clin Pharmacol 1994; 37:82-5.
13. Nix DE, Watson WA, Handy L, Frost RW, Rescott DL, Goldstein HR. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin. Pharmacotherapy 1982;9:377-80.
14. Williams J, Elleman TC, Kingston IB, Wilkins AG, Kuhn KA. The primary structure of hen ovotransferrin. Eur J Biochem 1982;122:297-303.
15. Banerjee D, Flanagan PP, Cluett J, Valberg LS. Transferrin receptors in the human gastrointestinal tract: relationship to body iron stores. Gastroenterology 1986;91:861-9.
16. Polk RE. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med 1989;87 (suppl 5A):76S-81S.
17. Vallée F, Le Bel M, Bergeron MG. Determination of ciprofloxacin in biological samples by reversed-phase high performance liquid chromatography. Ther Drug Monit 1986;8:340-5.
18. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA 1983; 80:1449-53.
19. Top products in 1994. SCRIP 1995;2040:23.
20. Campbell NRC, Kara M, Hasinoff BB, Haddara WM, McKay DA. Norfloxacin interaction with antacids and minerals. Br J Clin Pharmacol 1992;33: 115-6.
21. Lehto P, Kivistö KT. Different effects of products containing metal ions on the absorption of lomefloxacin. CLIN PHARMACOL THER 1994;56:477-82.
22. Greenberger NJ, Isselbacher KJ. Disorders of absorption. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, eds. Harrison's principles of internal medicine. New York: McGraw Hill, 1992;1252-68.
23. Brigden ML. Iron deficiency anemia: every case is instructive. Postgrad Med 1993;93:181;185-92.